10.07.2015 Views

2008 Summer Meeting - Leeds - The Pathological Society of Great ...

2008 Summer Meeting - Leeds - The Pathological Society of Great ...

2008 Summer Meeting - Leeds - The Pathological Society of Great ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

P111YY1 is a Prognostic Marker in Follicular LymphomaVE Clay 1 , JA Radford 2 , RJ Byers 21 Medical School, University <strong>of</strong> Manchester, 2 Cancer Studies, University <strong>of</strong>ManchesterFollicular lymphoma is the second most common type <strong>of</strong> Non-Hodgkin’sLymphoma worldwide. <strong>The</strong> majority <strong>of</strong> patients diagnosed with follicularlymphoma have an indolent, incurable form <strong>of</strong> the disease, however a subset <strong>of</strong>patients have aggressive disease with a shorter survival interval, but arepotentially curable. In order for the correct treatment options to be considered itis important to distinguish between these patients.<strong>The</strong> transcription factor YY1 has been shown to play an important role incancer biology. PolyA RT-PCR has recently identified YY1 mRNA as beingover-expressed in follicular lymphoma patients with a shorter survival interval.This study aimed to validate these findings at the protein level.Quantification <strong>of</strong> the YY1 protein was carried out on 26 follicularlymphoma biopsy samples using Quantum Dot labelled immunohistochemistry.Expression levels <strong>of</strong> the YY1 protein were significantly increased in thosepatients alive after follow-up, in comparison to those dead (P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!